Related by context. Frequent words. (Click for all words.) 69 statistically significant improvement 68 statistically significant 63 primary endpoint 62 placebo p = 61 primary efficacy endpoint 61 statistically significant differences 61 P = .# 60 statistically significant p 60 nonsignificant 60 clinically meaningful 60 secondary endpoints 60 placebo p 60 secondary endpoint 59 mg dose 59 placebo 59 p = #.# [002] 58 composite endpoint 58 p = #.# [004] 56 Secondary endpoints included 56 mcg kg 56 rotigotine 56 n = 56 thromboembolic events 56 non inferiority 56 statistical significance 56 plasma concentrations 56 demonstrated statistically significant 56 Secondary endpoints 55 primary endpoints 55 log# 55 p = 55 tiotropium 55 mg BID 54 IPSS 54 mg kg 54 valsartan 53 confidence interval CI 53 discontinuations due 53 bosentan 53 reach statistical significance 53 median PFS 53 hypercalcemia 53 monotherapy 53 % CI #.#-#.# [002] 53 dyspnea 53 clinically relevant 53 elagolix 52 sustained virologic response 52 ≥ 52 nasopharyngitis 52 pramipexole 52 severe hypoglycemia 52 bupivacaine 52 mg d 52 quetiapine 52 evaluable patients 52 adalimumab 52 FEV1 52 ramipril 52 % CI #.#-#.# [006] 52 limiting toxicity 52 evaluable 52 achieve statistical significance 52 efficacy endpoints 52 Phase 2a trial 52 LEVADEX 52 placebo controlled 51 certolizumab pegol 51 exacerbations 51 inverse association 51 leukopenia 51 LVEF 51 Secondary endpoints include 51 myocardial infarction MI 51 TIMI 51 dexamethasone 51 etanercept 51 febrile neutropenia 51 unfractionated heparin 51 postoperatively 51 μg 51 myocardial ischemia 51 Postoperative 51 dose limiting toxicities 51 zoledronic acid 51 randomized controlled 51 ticagrelor 50 pioglitazone 50 mg doses 50 mitoxantrone 50 sinus rhythm 50 fluticasone 50 ACR# [002] 50 g dL 50 creatinine clearance 50 thromboembolism 50 chronic angina 50 lacosamide 50 telmisartan 50 mmol L 50 elevated liver enzymes